Acetazolamide
Acetazolamide | CAS NO:59-66-5, Acetazolamide is used to treat edema (fluid retention) caused by heart failure or other medicines. This medicine is also used to treat seizures (eg, petit mal, unlocalized seizures).
We are the Synchemia Research Chemical specializes in manufacturing and supplying of Acetazolamide impurities that meet specific pharmacopeial standards (EP/BP/USP/IP) as well as process-related impurities. Acetazolamide is used to treat edema (fluid retention) caused by heart failure or other medicines. This medicine is also used to treat seizures (eg, petit mal, unlocalized seizures). Buy Reliable and High-Purity Acetazolamide Impurities, Delivered by Synchemia Research Chemicals.
Pharmaceutical Reference Standards
| CAT No | SRC-A826 |
| CAS No | 59-66-5 |
| Mol.F. | C4H6N4O3S2 |
| Mol.Wt. | 222.2g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-A827 |
| CAS No | 60320-32-3 |
| Mol.F. | C4H4ClN3OS |
| Mol.Wt. | 177.6g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-A828 |
| CAS No | 5393-55-5 |
| Mol.F. | C4H5N3OS |
| Mol.Wt. | 143.2g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-A829 |
| CAS No | 32873-56-6 |
| Mol.F. | C4H5N3OS2 |
| Mol.Wt. | 175.2g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-A830 |
| CAS No | 14949-00-9 |
| Mol.F. | C2H4N4O2S2 |
| Mol.Wt. | 180.2g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-A831 |
| CAS No | 827026-60-8 |
| Mol.F. | C4H5N3O4S2 |
| Mol.Wt. | 223.2g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-A832 |
| CAS No | 80495-47-2 |
| Mol.F. | C8H9N7O6S4 |
| Mol.Wt. | 427.4g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-A833 |
| CAS No | 2349-67-9 |
| Mol.F. | C2H3N3S2 |
| Mol.Wt. | 133.1g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-A834 |
| CAS No | NA |
| Mol.F. | C8H9N7O4S3 |
| Mol.Wt. | 363.4g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-A835 |
| CAS No | 50608-12-3 |
| Mol.F. | C7H13N3S |
| Mol.Wt. | 171.3g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
Let’s advance your research together.
Partner with us for specialized chemical materials and synthesis services that enable pharmaceutical innovation.